Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OBINUTUZUMAB for Chemotherapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 135 adverse event reports in the FDA FAERS database where OBINUTUZUMAB was used for Chemotherapy.

Most Reported Side Effects for OBINUTUZUMAB

Side Effect Reports % Deaths Hosp.
Off label use 1,584 11.2% 139 239
Neutropenia 1,276 9.0% 112 331
Febrile neutropenia 955 6.7% 91 473
Covid-19 942 6.6% 263 505
Pyrexia 920 6.5% 122 525
Thrombocytopenia 889 6.3% 77 164
Disease progression 831 5.9% 184 75
Infusion related reaction 789 5.6% 58 252
Pneumonia 662 4.7% 170 445
Anaemia 640 4.5% 53 111
Atrial fibrillation 548 3.9% 36 141
Infection 517 3.6% 69 94
Chills 483 3.4% 15 158
Dyspnoea 478 3.4% 59 187
Nausea 470 3.3% 37 166

Other Indications for OBINUTUZUMAB

Chronic lymphocytic leukaemia (4,557) Follicular lymphoma (2,527) Product used for unknown indication (1,743) B-cell lymphoma (1,200) Diffuse large b-cell lymphoma (1,193) Mantle cell lymphoma (441) Non-hodgkin's lymphoma (387) Lymphoma (238) Marginal zone lymphoma (188) Central nervous system lymphoma (133)

Other Drugs Used for Chemotherapy

CYCLOPHOSPHAMIDE (3,372) DOCETAXEL (2,134) CARBOPLATIN (1,902) DOXORUBICIN (1,756) VINCRISTINE (1,743) PACLITAXEL (1,425) OXALIPLATIN (1,423) METHOTREXATE (1,380) CYTARABINE (1,355) ETOPOSIDE (1,246)

Related Pages

OBINUTUZUMAB Full Profile All Chemotherapy Drugs OBINUTUZUMAB Demographics OBINUTUZUMAB Timeline